Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
Company announcement No. 26 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 25, 2026) Copenhagen, Denmark, June 22, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
Torrent Pharma Stock Surges on Robust India Growth, Strong Margins & Favourable Outlook
Torrent Pharma is gaining significant attention from brokerages as its robust India revenue growth and expanding margins position it as a top sectoral pick, driving a substantial 44 per cent return over the past year. Torrent Pharma is a top…
LSL PHARMA GROUP ANNOUNCES VOTING RESULTS OF ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
BOUCHERVILLE, QC, June 22, 2026 /CNW/ - LSL PHARMA GROUP INC. (TSXV: LSL) ('LSL Pharma' or the 'Corporation'), a Canadian integrated pharmaceutical company, today announced the voting results of its annual general and special meeting of…
Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes. This milestone reflects the Company's long-range…
Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company
The U.S. Federal Trade Commission (FTC) has approved Aurobindo Pharma's proposed acquisition of Pennsylvania-based generic pharmaceutical firm Lannett Company. Valued at $250 million on a cash-free, debt-free basis and inclusive of normalised…
Stock markets begin week by ending higher
Stock markets rebounded on Monday with the benchmark Sensex gaining 291 points following a decline in crude oil prices and supportive global cues amid hopes of diplomatic progress in US-Iran talks. The 30-share BSE Sensex climbed 291.17 points, or…
Sun Pharma, Aurobindo Pharma, Tata Motors, Aavas Financiers, Patanjali, Power Mech, RVNL and 20 more stocks will remain in focus on Monday , June 22
Sun Pharmaceutical Industries on Saturday said it will acquire 100% of Innovcare Lifesciences in an all-cash deal valued for ₹271 crore ($28.73 million). Sun Pharma said it has signed an agreement to acquire 100 per cent of the outstanding…
Aurobindo Pharma gets US FTC's nod to acquire Lannett Company
Aurobindo Pharma 's wholly owned arm in the US has received approval from the US Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC. The transaction, valued at $250 million on a cash-free, debt-free basis and…
Pharmalittle: We're reading about another FDA reversal, pharma's M&A spree and much more
Good morning, everyone, and welcome to another working week. We hope the weekend respite — longer than usual thanks to a holiday on this side of the pond — was relaxing and invigorating. Now, though, that oh-too-familiar routine of…
Nifty holds above 24,100 at midday; Pharma, IT lead gains as breadth stays strong
Markets held steady in mid-session trade on Monday, June 22, with the Sensex up 368.39 points or 0.48 per cent at 77,171.29 and the Nifty 50 gaining 108.65 points or 0.45 per cent to trade at 24,121.75 as of 12:57 pm. Markets have broadly sustained…
Indian Stock Market Rises: Sensex, Nifty Gain on Lower Crude Oil, US-Iran Diplomacy Hopes
Indian stock markets witnessed a significant rebound, with the Sensex and Nifty closing higher, as softening crude oil prices and optimistic global cues surrounding US-Iran diplomatic progress bolstered investor confidence. Indian benchmark…
5 More AI Predictions For The Year 2030
Prediction #2: TSMC's and ASML's monopolies will be broken. The semiconductor supply chain will be dramatically transformed. Two years ago, we published a list of 5 predictions about AI in the year 2030. The article sparked a lot of fascinating…
Press Release: Sanofi appoints Paulo Fontoura as Global Head of R&D
Sanofi appoints Paulo Fontoura as Global Head of R&D Paris, June 22, 2026. Sanofi today announced the appointment of Paulo Fontoura, MD, PhD, FAAN, as Executive Vice President, Global Head of Research & Development Pharma, effective September 1…
Sensex, Nifty Close Higher as Oil Prices Ease; FII Buying and US-Iran Talks Lift Sentiment
Benchmark equity indices, the Sensex and Nifty, ended Monday's trading session in positive territory, supported by a sharp decline in crude oil prices and firm global cues amid hopes of diplomatic progress in the US-Iran talks. Investor sentiment…
UnitedHealth (UNH) Takes Major Step Toward Resolving FTC Insulin Pricing Dispute
With a short percentage of shares outstanding of 2.12%, UnitedHealth Group Incorporated (NYSE: UNH) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June 12, subsidiaries of UnitedHealth Group Incorporated (NYSE:UNH), including…
Receive a Daily briefing on Pharma Industry News
Get Started